State-Level Policies
CA AB 824 (pay-for-delay)
Resources
PBGH Letter to Senator Hannah-Beth Jackson in support of AB 824 (Wood)
PBGH Letter written to Senator Hannah-Beth Jackson in support of Bill AB 824 (Wood) prohibiting agreements in which drug manufacturers pay generic companies to delay the introduction of lower-price medications to the market.
Assembly Floor Analysis – ASSEMBLY THIRD READING AB 824 (Wood)
According to an FTC study, these anticompetitive deals cost consumers and taxpayers $3.5 billion in higher drug costs every year.